Filing Details

Accession Number:
0000950170-23-068064
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-05 14:30:45
Reporting Period:
2023-12-02
Accepted Time:
2023-12-05 14:30:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1707502 Solid Biosciences Inc. SLDB Biological Products, (No Disgnostic Substances) (2836) 900943402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1954826 Jessie Hanrahan C/O Solid Biosciences
500 Rutherford Avenue, Third Floor
Charlestown MA 02129
Chief Regulatory Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-02 11,862 $0.00 11,862 No 4 M Direct
Common Stock Disposition 2023-12-04 4,879 $2.78 6,983 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-12-02 11,862 $0.00 11,862 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,587 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
  2. This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
  3. The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.